On Oct 17, major Wall Street analysts update their ratings for $Walgreens Boots Alliance (WBA.US)$, with price targets ranging from $7 to $8.
Morgan Stanley analyst Erin Wright maintains with a sell rating, and maintains the target price at $7.
BofA Securities analyst Allen Lutz maintains with a sell rating, and maintains the target price at $7.5.
Barclays analyst Stephanie Davis maintains with a sell rating, and adjusts the target price from $7 to $8.
Truist Financial analyst David S Macdonald maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Walgreens Boots Alliance (WBA.US)$'s main analysts recently are as follows:
The CEO of Walgreens Boots Alliance expressed considerable optimism about the company's direction, citing 'the best day he's had as CEO' since his tenure began in late 2023, which was partly due to positive stock reactions and encouraging results. There is an anticipation of a recovery in adjusted earnings per share and reported free cash flow, but projections suggest this may not materialize for at least another year or two. It is believed that potential divestitures of certain business units could significantly accelerate the improvement in earnings and cash flow.
The latest quarterly report from Walgreens Boots Alliance offered guidance for fiscal 2025 and provided data that helped ease concerns regarding short-term liquidity. Despite this, there remain ongoing structural challenges within the U.S. retail pharmacy sector.
Walgreens Boots Alliance's recently presented financial outlook for FY25, which was anticipated, offers a logical projection for the company's trajectory despite numerous variables. It is acknowledged that observing the core AOI of the business diminish by half year-over-year is not ideal. Nonetheless, the forecast aligns with expectations and incorporates a sensible perspective on reimbursement, headwinds from one year to the next, and potential growth. Attention now pivots to the company's operational execution, especially the impact of store closures and enhancements in working capital, which will likely be scrutinized by investors until a stable pattern of these modifications emerges.
Here are the latest investment ratings and price targets for $Walgreens Boots Alliance (WBA.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月17日，多家華爾街大行更新了$沃爾格林-聯合博姿 (WBA.US)$的評級，目標價介於7美元至8美元。
摩根士丹利分析師Erin Wright維持賣出評級，維持目標價7美元。
美銀證券分析師Allen Lutz維持賣出評級，維持目標價7.5美元。
巴克萊銀行分析師Stephanie Davis維持賣出評級，並將目標價從7美元上調至8美元。
儲億銀行分析師David S Macdonald維持持有評級。
此外，綜合報道，$沃爾格林-聯合博姿 (WBA.US)$近期主要分析師觀點如下：
沃爾格林-聯合博姿的首席執行官對公司方向表示了相當樂觀，稱其自2023年底開始擔任CEO以來有過的"最好的一天"，部分原因是股價的積極反應和令人鼓舞的業績。有人預計調整後的每股收益和報告的自由現金流將出現恢復，但預測表明這可能至少需要再過一到兩年。一種看法認爲，潛在的出售特定業務部門可能會顯著加快盈利和現金流的改善。
沃爾格林-聯合博姿最近發佈的季度報告爲2025財年提供了指導，並提供了有助於緩解短期流動性擔憂的數據。儘管如此，美國零售藥店行業仍存在持續的結構性挑戰。
沃爾格林-聯合博姿最近提出的2025財年財務展望，符合預期，爲公司的發展軌跡提供了合乎邏輯的預測，儘管存在許多變數。人們認識到，業務核心的AOI每年下降一半並不理想。儘管如此，這一預測符合預期，並融入了對報銷情況、一年比一年面臨的逆風以及潛在增長的合理看法。注意現在轉向公司的運營執行，特別是商店關閉的影響以及營運資本的增強，這將受到投資者的關注，直到這些修改的穩定模式出現。
以下爲今日4位分析師對$沃爾格林-聯合博姿 (WBA.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
